Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
ANAPTYSBIO, INC (ANAB) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/10/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Anaptys Announces Positive Top-Line Phase 3 Clinical Trial Results of Imsidolimab"
10/02/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
08/07/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/07/2023 8-K Quarterly results
Docs: "AnaptysBio Announces Second Quarter 2023 Financial Results and Provides Business Update"
06/15/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/11/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/11/2023 8-K Quarterly results
Docs: "AnaptysBio Announces First Quarter 2023 Financial Results and Provides Pipeline Update"
04/27/2023 ARS Form ARS - Annual Report to Security Holders:
04/27/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/27/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/14/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
04/06/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/01/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
03/01/2023 10-K Annual Report for the period ended December 31, 2022
03/01/2023 8-K Quarterly results
Docs: "AnaptysBio Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update"
02/10/2023 8-K Quarterly results
02/10/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/09/2023 SC 13G/A VANGUARD GROUP INC reports a 6.2% stake in AnaptysBio Inc.
02/09/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/01/2023 SC 13G/A FEDERATED HERMES, INC. reports a 8.4% stake in ANAPTYSBIO, INC.
01/05/2023 8-K Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits  I...
Docs: "AnaptysBio Announces Portfolio Update Across Best-in-Class Immune Cell Modulating Antibodies",
"Corporate Overview January 2022 Nasdaq: ANAB"
11/08/2022 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
11/08/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/08/2022 8-K Quarterly results
09/12/2022 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits  Inte...
Docs: "Corporate Overview September 2022 Nasdaq: ANAB"
09/09/2022 SC 13G Point72 Asset Management, L.P. reports a 8.1% stake in AnaptysBio, Inc.
08/31/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "AnaptysBio Reports HARP Phase 2 Top-Line Data of Imsidolimab in Moderate-to-Severe Hidradenitis Suppurativa"
08/15/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
08/08/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/08/2022 8-K Quarterly results
06/24/2022 8-K Quarterly results
05/10/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
05/04/2022 10-Q Quarterly Report for the period ended March 31, 2022
05/04/2022 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy